Consonance Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,558,290	Closed	-$3.04M	–	36
2020 Q4	$3.04M	Hold	1,558,290	–	–	0.28%	32
2020 Q3	$3.72M	Sell	1,558,290 -1,100,000	-41%	-$3.02M	0.45%	24
2020 Q2	$7.79M	Sell	2,658,290 -725,000	-21%	-$2.08M	0.47%	28
2020 Q1	$9.74M	Sell	3,383,290 -1,783,671	-35%	-$6.17M	0.73%	27
2019 Q4	$20.7M	Buy	5,166,961 +51,975	+1%	+$227K	1.26%	27
2019 Q3	$22.8M	Sell	5,114,986 -590,366	-10%	-$2.47M	2.25%	19
2019 Q2	$22.1M	Buy	5,705,352 +1,117,000	+24%	+$4.93M	1.56%	21
2019 Q1	$17.4M	Hold	4,588,352	–	–	1.1%	21
2018 Q4	$11M	Buy	4,588,352 +49,057	+1%	+$243K	0.81%	20
2018 Q3	$28.2M	Buy	4,539,295 +290,061	+7%	+$1.67M	1.52%	23
2018 Q2	$19.2M	Buy	4,249,234 +920,000	+28%	+$4.59M	1.24%	22
2018 Q1	$15.3M	Sell	3,329,234 -38,401	-1%	-$153K	1.4%	20
2017 Q4	$10.8M	Buy	3,367,635 +2,093,702	+164%	+$5.86M	0.98%	19
2017 Q3	$3.92M	Hold	1,273,933	–	–	0.43%	17
2017 Q2	$4.71M	Hold	1,273,933	–	–	0.56%	17
2017 Q1	$6.22M	Hold	1,273,933	–	–	0.65%	21
2016 Q4	$6.52M	Hold	1,273,933	–	–	0.72%	20
2016 Q3	$9.22M	Hold	1,273,933	–	–	0.89%	18
2016 Q2	$7.58M	Buy	1,273,933 +213,916	+20%	+$1.5M	1.07%	17
2016 Q1	$8.58M	Hold	1,060,017	–	–	1.3%	16
2015 Q4	$8.55M	Buy	1,060,017 +7,875	+0.7%	+$70.9K	1.15%	13
2015 Q3	$8.8M	Buy	1,052,142 +17,421	+2%	+$161K	1.24%	16
2015 Q2	$9.58M	Buy	1,034,721 +48,214	+5%	+$417K	0.96%	19
2015 Q1	$9.67M	Buy	986,507 +109,100	+12%	+$1.1M	0.88%	22
2014 Q4	$9.8M	Buy	+877,407	New	+$10M	1.26%	16

Other funds holding ADMA